Sb. Penner et Dd. Smyth, THE ROLE OF THE PERIPHERAL SYMPATHETIC NERVOUS-SYSTEM IN THE NATRIURESIS FOLLOWING CENTRAL ADMINISTRATION OF AN I-1 IMIDAZOLINE AGONIST, MOXONIDINE, British Journal of Pharmacology, 116(6), 1995, pp. 2631-2636
1 Central administration of the I-1-imidazoline receptor agonist moxon
idine increases sodium excretion without alteration of blood pressure.
In the present study we determined whether this natriuretic action wa
s mediated through a decrease in activity of the sympathetic nervous s
ystem, as has been reported for the antihypertensive action of this co
mpound. Interruption of the sympathetic nervous system was achieved wi
th prazosin (alpha(1)-adrenoceptor antagonist) and renal denervation.
2 In pentobarbitone-anaesthetized Sprague-Dawley rats, intracerebroven
tricular (i.c.v.) injection of moxonidine alone increased urine volume
and sodium excretion. Prazosin (0.15 mg kg(-1), i.v.) alone decreased
urine flow rate and sodium excretion as compared to the vehicle contr
ols. In the presence of prazosin, i.c.v. injection of moxonidine faile
d to increase sodium excretion or urine volume as compared to animals
which received the prazosin alone. 3 The administration of moxonidine
(i.c.v.) to sham renal-denervated animals caused an increase in urine
flow rate, urine sodium excretion, osmolar clearance and free water cl
earance. The increase in sodium excretion and osmolar clearance were c
ompletely attenuated in renal denervated rats, however, urine flow rat
e was still increased and this was secondary to the increase in free w
ater clearance which remained intact. 4 These results indicate the imp
ortance of an intact sympathetic nervous system in the renal response
to i.c.v. moxonidine. Moreover, the differential antagonism of these i
nterventions on solute and water excretion indicate that they may be m
ediated at two separate sites and/or receptors following i.c.v. moxoni
dine.